Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT06307288Phase 4Enrolling by invitation
A Phase 4 trial of tranilast in rosacea, sponsored by Second Affiliated Hospital of Xi'an Jiaotong University. Started Oct 2023; status: enrolling by invitation.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT06307288.